The Global Viral Vector Manufacturing Market is estimated to grow at a CAGR of around 19.22% during the forecast period, i.e., 2024-30. This growth trajectory is primarily attributed to two key factors, i.e., the escalating incidence of epidemics and pandemics, which has expedited vaccine development efforts, and the mounting investments in gene therapy initiatives.
|
A note to our visitors
This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy. Privacy Policy |
|
Leave feedback about this